A study to evaluate the efficacy of Poovarasu nei in childrens having itching and abnormal colour of skin

An open clinical study on Bala karappan (Atopic Dermatitis) in children with the evaluation of Siddha trial drug Poovarasu nei (Internal)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009651

Enrollment

Registered

2017-09-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bala Karappan (Atopic Dermatitis)

Interventions

Intervention1: Poovarasu nei: Dosage of Poovarasu nei is 4 ml, once in morning only. Duration for administration of trial drug is 28 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Severe itching 2. Erythema 3. Oozing 4. Vesicles 5. Lichenification

Exclusion criteria

Exclusion criteria: 1. Scabies 2. Photo Dermatitis 3. Secondary bacterial infection 4. Furunculosis

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by comparig the reduction in clinical symptoms and recurrence before and after treatmentTimepoint: Primary outcome is mainly assessed by comparig the reduction in clinical symptoms and recurrence before and after treatment	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr R Bharathi Sri

Govt Siddha Medical College

cspriya2004@gmail.com9444312671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026